Michael J. Blaha Profile Banner
Michael J. Blaha Profile
Michael J. Blaha

@MichaelJBlaha

Followers
4,147
Following
610
Media
88
Statuses
2,819

Preventive Cardiology, Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, @CiccaroneCenter

Johns Hopkins Hospital
Joined February 2013
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
@MichaelJBlaha
Michael J. Blaha
3 years
I just head some great news! The great Dr. Pam Taub has been promoted to Professor at UCSD. Congratulations to Professor Taub, a leader in cardiometabolic disease! @CBallantyneMD @NMHheartdoc @DLBHATTMD @DrMarthaGulati @ErinMichos @ASPCardio
Tweet media one
22
11
154
@MichaelJBlaha
Michael J. Blaha
9 months
I think these SELECT top line results are the most important for preventive cardiology since the JUPITER trial. Incredible implications for our field.
5
39
131
@MichaelJBlaha
Michael J. Blaha
1 year
I will be recruiting for a new preventive cardiology / cardiometabolic medicine fellow @CiccaroneCenter for 2023. Now that Match is done, futures are being planned. If interested in this 1 or 2 year position, please DM me.
9
44
131
@MichaelJBlaha
Michael J. Blaha
5 months
It is time again to recruit for our Cardiometabolic Fellowship in the Johns Hopkins Ciccarone Center. This is dedicated for those with SPECIFIC interest in preventive cardiology and cardiometabolic disease. If interested, please DM me and I will ask for your CV and PS.
16
29
117
@MichaelJBlaha
Michael J. Blaha
3 years
Here is a nice summary of the new paper on warranty of CAC=0 from MESA.
Tweet media one
5
24
104
@MichaelJBlaha
Michael J. Blaha
3 years
New in @JACCJournals : Modeling the Recommended Age for Initiating Coronary Artery Calcium Testing in At-Risk Young Adults
3
29
80
@MichaelJBlaha
Michael J. Blaha
5 years
All cardiologists should push back against incorrect comments that CAC costs $800-1000. That is even high for CTA. CAC most commonly costs $75-200. @CNN
20
25
81
@MichaelJBlaha
Michael J. Blaha
3 years
US FDA approves Jardiance® (empagliflozin) to treat adults living with heart failure with reduced ejection fraction
0
26
79
@MichaelJBlaha
Michael J. Blaha
5 years
So happy for my two star senior research fellows! @HassanMirbolouk matched at Yale, and @solaorimoloye matched at Vanderbilt (one of my alma maters). Continues the great @CiccaroneCenter tradition! Can't wait to see development of my next group.
Tweet media one
Tweet media two
8
25
77
@MichaelJBlaha
Michael J. Blaha
2 years
Just received my first copy. Great new textbook to check out, very comprehensive 111 chapters covering cardiovascular medicine and surgery.
Tweet media one
1
10
73
@MichaelJBlaha
Michael J. Blaha
3 years
@dmljmd @JAMAInternalMed One of the most uninformed pieces I have ever read. The wrong message to send patients in 2021. Instead, we should follow our many great guidelines on this topic.
3
14
68
@MichaelJBlaha
Michael J. Blaha
2 years
A Simple Approach to the Identification of Guideline-Based Coronary Artery Calcium percentiles - MESA.
Tweet media one
0
18
61
@MichaelJBlaha
Michael J. Blaha
3 years
Just published in JACC Imaging: Warranty Period of a Calcium Score of Zero
1
10
58
@MichaelJBlaha
Michael J. Blaha
3 years
New @JACCJournals article - Coronary Artery Calcium Scoring for Adults at Borderline 10-Year ASCVD Risk: CAC Consortium.
1
14
53
@MichaelJBlaha
Michael J. Blaha
3 years
Multi-Ethnic Study of Atherosclerosis (MESA): JACC Focus Seminar 5/8
5
12
50
@MichaelJBlaha
Michael J. Blaha
3 years
Important Topic! New paper in JCL - Coronary artery calcium scoring in patients with statin associated muscle symptoms
1
12
43
@MichaelJBlaha
Michael J. Blaha
3 years
Nice summary figure. Greatful that NLA considered use of CAC for decisions beyond lipids as well. Very useful statement in my view.
@RonBlankstein
Ron Blankstein
3 years
National Lipid Association Releases Official Scientific Statement on Coronary Artery Calcium Scoring for ASCVD Risk Reduction
Tweet media one
6
95
242
1
4
38
@MichaelJBlaha
Michael J. Blaha
7 years
Is it time to construct a new coronary artery calcium score?
Tweet media one
5
19
39
@MichaelJBlaha
Michael J. Blaha
3 years
Impact of Plaque Burden Versus Stenosis on Ischemic Events in Patients With Coronary Atherosclerosis:
Tweet media one
0
4
36
@MichaelJBlaha
Michael J. Blaha
2 years
From @jaccjournals : Mean Versus Peak Coronary Calcium Density on Non-Contrast CT: Novel Approaches to Calcium Scoring and ASCVD Risk Prediction. Implications for early CAC.
Tweet media one
0
10
34
@MichaelJBlaha
Michael J. Blaha
1 year
@MBittencourtMD @khurramn1 @drjohnm @rblument1 @BudoffMd @DrRumberger @drmikefarkouh @DrMarthaGulati "Calcification is part of aging process" is extremely poorly informed. Healthy endothelial cells actually secret proteins inhibiting calcification. It's a pathologic process. As per Marcio, CAC burden in the Tsimane hunter-gatherers is required reading:
1
10
34
@MichaelJBlaha
Michael J. Blaha
3 years
Pooled Cohort Equations and the competing risk of cardiovascular disease vs. cancer
2
13
33
@MichaelJBlaha
Michael J. Blaha
6 years
What an incredible day for cardiovascular prevention! Dapagliflozin meets one of its primary endpoints, solidifying the SGLT2i class with 3 CVOTs an CVD-REAL, and this is back page news given the REDUCE-IT study!
0
8
32
@MichaelJBlaha
Michael J. Blaha
5 years
I just had a great academic trip to London. I rarely share on social media, but must share quite note on my inspiring trip to Albert Street where I was lived after being born. Walked route mom took me to to regents park.
Tweet media one
0
0
32
@MichaelJBlaha
Michael J. Blaha
5 years
Strong argument for the unique nature of CAC >1000. Risk exceeds that of FOURIER trial group.
Tweet media one
4
12
31
@MichaelJBlaha
Michael J. Blaha
4 years
Trends in e-Cigarette Use in Adults in the United States, 2016-2018 via @JAMAInternalMed part of @JAMANetwork
Tweet media one
1
17
29
@MichaelJBlaha
Michael J. Blaha
3 years
Very important paper, very important concept for clinical practice and aggressive prevention.
@MaBMortensen
Martin Bødtker Mortensen
3 years
Are all pts with obstruc. CAD at equally high risk for subsequent events? Are their risk always⬆️than patients with non-obstruc. CAD? In our @JACCJournals paper we show that 5yr risk varies considerably based on CAD severity and RFs.
Tweet media one
1
11
28
0
6
27
@MichaelJBlaha
Michael J. Blaha
1 year
Reminder - open to anyone interested in obesity research and treatment - @MichaelAlbertMD today at 200 PM EST. @CiccaroneCenter . Link:
Tweet media one
5
4
25
@MichaelJBlaha
Michael J. Blaha
4 years
@CircAHA @CBallantyneMD @vijay_nambi Everyone knows a CAC score can be repeated right? See data from MESA (). Events paper to be out shortly. Persistent Zero --> low risk, new CAC --> higher risk. Doesn't have to be one-time life decision at age 40 (statin for life vs. never statin).
3
9
27
@MichaelJBlaha
Michael J. Blaha
3 years
The evolving role of coronary computed tomography in understanding sex differences in coronary atherosclerosis.
0
12
26
@MichaelJBlaha
Michael J. Blaha
3 years
New Insights into Prescribing of SGLT2 Inhibitors and GLP-1 Receptor Agonists by Cardiologists in 2020: Major Barriers Limiting Role - American College of Cardiology
0
8
26
@MichaelJBlaha
Michael J. Blaha
3 years
Assessing the Impact of Coronary Plaque on the Relative and Absolute Relative Risk Reduction with Statin Therapy @JACCJournals @CiccaroneCenter
1
9
26
@MichaelJBlaha
Michael J. Blaha
6 years
Incredible views of lower Manhattan yesterday from jersey city.
Tweet media one
0
0
25
@MichaelJBlaha
Michael J. Blaha
5 years
A reasonable approach to new onset chest pain of suspected cardiac cause that could be widely adopted, with anticipated long-term benefit.
Tweet media one
3
12
25
@MichaelJBlaha
Michael J. Blaha
2 years
Thought question: If a patient had significant coronary plaque, very high Lp(a), but NO measurable 'real" LDL (all Lp(a)), do you think a statin would still improve outcomes?
No, statins work thru LDL
54
Yes-statins modify plaque
181
Other (please explain)
28
14
3
24
@MichaelJBlaha
Michael J. Blaha
4 years
What is the warranty period of a CAC score of zero in MESA?
Tweet media one
1
5
24
@MichaelJBlaha
Michael J. Blaha
6 years
New important study in @JACCJournals : Impact of C-Reactive Protein and Coronary Artery Calcium on Benefit Observed With Atorvastatin - St. Francis Heart RCT. See image below.
Tweet media one
0
12
23
@MichaelJBlaha
Michael J. Blaha
7 years
Wow, did I read this right? A colleague claims statins often cause muscle symptoms in more than 50% of patients? Data?
Tweet media one
7
4
22
@MichaelJBlaha
Michael J. Blaha
2 years
Opinion poll: An invitation for which test is more likely to reduce mortality?
Colonscopy
107
Non-constrast cardiac CT
167
Mammography
121
PSA
10
7
11
20
@MichaelJBlaha
Michael J. Blaha
3 years
Wow fantastic from Karen Alexander and Pam Douglas. Chest Pain Redux: Updated and Patient-centered
0
3
21
@MichaelJBlaha
Michael J. Blaha
2 years
@JAMACardio Incredibly misleading tweet here by the journal. Please read the full paper not the tweet. Obstructive coronary disease very rare in young patients. @MaBMortensen
4
6
21
@MichaelJBlaha
Michael J. Blaha
2 years
E-cigarette Use and Risk of Cardiovascular Disease: A Longitudinal Analysis of the PATH Study, 2013-2019
2
9
18
@MichaelJBlaha
Michael J. Blaha
6 years
Super wow! My initial reaction is that this is the biggest finding for my everyday CV care in the lipid space since JUPITER.
3
1
20
@MichaelJBlaha
Michael J. Blaha
6 years
About our recent paper in NYT: From 0 to 10 Million: Vaping Takes Off in the U.S.
0
11
20
@MichaelJBlaha
Michael J. Blaha
3 years
Evaluation of Sotagliflozin in Patients with Type 2 Diabetes with Chronic Kidney Disease or Acute Exacerbation of Heart Failure: the SCORED and SOLOIST-WHF Trials - American College of Cardiology
0
4
19
@MichaelJBlaha
Michael J. Blaha
3 years
This figure sure makes sense to me.
@khurramn1
Khurram Nasir
3 years
Finally this conservative & compromised approach can not only incorporate #PowerOfZero in CP diagnostic algorithms and still reassure those still on the fence Let common sense prevail and... Time to at least acknowledge if not completely accept #PowerOfZero for stable CP pts
Tweet media one
0
7
21
1
0
19
@MichaelJBlaha
Michael J. Blaha
6 years
Does Trump have heart disease? it depends on who you ask (and they asked me!) via @HuffPost
2
9
19
@MichaelJBlaha
Michael J. Blaha
2 years
@MaBMortensen @miguelcainzos23 @khurramn1 Amazing job by Dr. Martin Mortensen! Becoming a consistent findings, here is the data from MESA @MKIttlesonMD
Tweet media one
3
5
19
@MichaelJBlaha
Michael J. Blaha
3 years
Is the coronary artery calcium scan a proven tool to improve prediction of heart attack risk?
Yes
401
No
165
5
9
18
@MichaelJBlaha
Michael J. Blaha
6 years
Highlights of #SCCT2018 for me: seeing friends, jeopardy (as always), prevention symposium, gladiators, also chest pain in ED very good session.
0
2
18
@MichaelJBlaha
Michael J. Blaha
2 years
If a large randomized screening trial included CAC measurement and long-term follow-up, what would be the ideal outcome to demonstrate benefit of screening?
Myocardial Infarction
25
MACE
107
Cardiovascular Death
36
All Cause Mortality
59
3
9
17
@MichaelJBlaha
Michael J. Blaha
6 years
Framingham at 70: What We’ve Learned About Women and Heart Disease
0
10
17
@MichaelJBlaha
Michael J. Blaha
4 years
Management of Stable Coronary Artery Disease in Patients with Diabetes Mellitus - American College of Cardiology
0
6
17
@MichaelJBlaha
Michael J. Blaha
3 years
@JAMACardio Key figures from paper.
Tweet media one
Tweet media two
1
3
16
@MichaelJBlaha
Michael J. Blaha
4 years
Incidence of New Coronary Calcification
2
3
17
@MichaelJBlaha
Michael J. Blaha
5 years
In light of national conversation, remember this critical paper in Annals: E-Cigarette Use Without a History of Combustible Cigarette Smoking Among U.S. Adults | Ann Intern Med | ACP |
0
6
16
@MichaelJBlaha
Michael J. Blaha
6 years
The prevalence and correlates of subclinical atherosclerosis among adults with low-density lipoprotein cholesterol <70 mg/dL: The Multi-Ethnic Stud... - PubMed - NCBI
0
9
15
@MichaelJBlaha
Michael J. Blaha
2 years
9/14 Important – what is mechanism of potential benefit? Not revascularization or surgery, no more AF detected, BP control similar. Answer - medical therapy: Aspirin first and of course statin (Table S5 in paper).
Tweet media one
2
3
16
@MichaelJBlaha
Michael J. Blaha
1 year
This is a clinical/research position, so US medical license required, can be post residency or post fellowship.
0
2
16
@MichaelJBlaha
Michael J. Blaha
7 years
The MESA Risk Score app is now available for iPhone:
Tweet media one
1
13
16
@MichaelJBlaha
Michael J. Blaha
9 months
@BevTchangMD @DrMichaelShapir @DrMarthaGulati @DrEugeneYang @ErinMichos I think the comparison here is to the drugs we consider after statins (so called residual risk). Semaglutide for weight loss appears to have stronger RRR than further LDL lowering for example (and perhaps CV mortality benefit).
2
0
15
@MichaelJBlaha
Michael J. Blaha
6 years
The Asymptomatic Patient: Risk Factor Score or Calcium Score? - American College of Cardiology
2
7
15
@MichaelJBlaha
Michael J. Blaha
3 years
Very important data.
0
2
15
@MichaelJBlaha
Michael J. Blaha
7 years
CANTOS, EMPA-REG, LEADER, CANVAS, SUSTAIN6 - more options for improved CV outcomes! I'l be looking at CV mortality results across trials
0
6
14
@MichaelJBlaha
Michael J. Blaha
6 years
Cheers to all those more proud of their kids than of any grant or paper. Central Maryland Champion swim team!
Tweet media one
0
1
14
@MichaelJBlaha
Michael J. Blaha
3 years
@khurramn1 @rauldsf_santos @ChristianDalPo1 @MBittencourtMD @marciominame @MaBMortensen @JohnJeffreyCarr Calculator for predicting this will be out soon, very excited about a study from CAC Consortium
0
2
14
@MichaelJBlaha
Michael J. Blaha
2 years
@BrettSperryMD @JAMACardio @MaBMortensen Agree that "meaning" section lacks context! Should be: obstructive cad rare in very young, but in rare cases when present, up to 50% can be purely noncalcified, particularly for age <40.
1
3
13
@MichaelJBlaha
Michael J. Blaha
3 years
4th place in States (100 & 200 breast) for a very special 13 year old, no tech suit. @eagleswimteam
@CoachWard81
Scott Ward
3 years
Just posted a photo
0
0
0
0
0
13
@MichaelJBlaha
Michael J. Blaha
6 years
Erectile Dysfunction as an Independent Predictor of Future Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis
2
9
12
@MichaelJBlaha
Michael J. Blaha
3 years
Amazing paper by the great Dr. Mortensen.
@MaBMortensen
Martin Bødtker Mortensen
3 years
Proud of our JACC paper showing that "plaque burden, not stenosis, is the main predictor of CVD events". Important data that challenge the current primary/secondary prevention paradigm where focus mainly is on lumen stenosis when quantifying CAD severity.
Tweet media one
13
91
354
1
1
13
@MichaelJBlaha
Michael J. Blaha
2 years
@JAMACardio @MaBMortensen Findings for those with cac zero in this symptomatic population.
Tweet media one
2
3
13
@MichaelJBlaha
Michael J. Blaha
6 years
On way back to Baltimore. Enjoyed #SCCT2018 and also time with my family visiting Dallas and Forth Worth. Work and family creates balance.
1
0
13
@MichaelJBlaha
Michael J. Blaha
3 years
Conclusions from this study have already been incorporated into new guidelines on lipid management from the Endocrine Society:
@CardioOBDoc
Parham Eshtehardi MD
3 years
What’s Warranty Period of a Calcium Score #CAC of Zero? Comprehensive Analysis From #MESA @JACCJournals @MichaelJBlaha
Tweet media one
0
23
57
0
6
13
@MichaelJBlaha
Michael J. Blaha
4 years
Unmet Role of Cardiologists: Use of Cardiometabolic Drugs that Lower Cardiovascular Risk - American College of Cardiology
0
1
12
@MichaelJBlaha
Michael J. Blaha
6 years
What is your guess about the results of the CIRT study?
Very positive (>15% RRR)
33
Mild positive (5-15% RRR)
35
No net benefit (ben=harm)
39
No benefit, mild harm
23
4
7
11
@MichaelJBlaha
Michael J. Blaha
5 years
Great quotes by @pnatarajanmd and great picture of @rblument1 !
@boback
Boback Ziaeian 🤦🏻‍♂️
5 years
'The Patient Has the Power' in New AHA/ACC Cholesterol Guideline @rblument1
2
11
19
1
4
12
@MichaelJBlaha
Michael J. Blaha
3 years
Pretty awesome
0
0
12
@MichaelJBlaha
Michael J. Blaha
2 years
14/14 While we debate, impressive to think that study may have saved 108 Danish lives (can also debate this calculation). Lots to unpack in this trial.
Tweet media one
0
4
12
@MichaelJBlaha
Michael J. Blaha
3 years
Important study
@dramitkhera
Amit Khera
3 years
SAMPSON- n of 1 trial: Most of statin intolerance from "act of taking tablets, rather than what is in them" Symptoms are real, but helpful communication item for shared decision making @NEJM #AHA2020 @dmljmd @ErinMichos @DrMarthaGulati @SethShayMartin
Tweet media one
3
17
75
0
2
12
@MichaelJBlaha
Michael J. Blaha
5 years
Selective Use of Coronary Artery Calcium Testing | Ann Intern Med | ACP |
1
5
12
@MichaelJBlaha
Michael J. Blaha
3 years
Awesome paper
@MaBMortensen
Martin Bødtker Mortensen
3 years
Really proud and excited about our new paper in Lancet demonstrating that elevated LDL-C in those aged 70-100 years is associated with increased risk of MI and ASCVD. In fact, per 1 mmol/L increase in LDL-C the relative risk is increased similarly to those aged 50-70 years.
0
7
23
0
1
11